Serum Cholesterol Levels and the Risk of Parkinson's Disease
Identifieur interne : 001204 ( Main/Exploration ); précédent : 001203; suivant : 001205Serum Cholesterol Levels and the Risk of Parkinson's Disease
Auteurs : Lonneke M. L. De Lau ; Peter J. Koudstaal ; Albert Hofman ; Monique M. B. BretelerSource :
- American Journal of Epidemiology [ 0002-9262 ] ; 2006-11-15.
English descriptors
- KwdEn :
Abstract
Several recent findings suggest a role of lipid and cholesterol metabolism in the pathogenesis of Parkinson's disease. Therefore, the authors examined the association between serum levels of cholesterol and the risk of Parkinson's disease in the prospective, population-based Rotterdam Study among 6,465 subjects aged 55 or more years with repeated in-person examination and on average 9.4 years of follow-up (1990–2004). Higher serum levels of total cholesterol were associated with a significantly decreased risk of Parkinson's disease (age- and sex-adjusted hazard ratio per mmol/liter increase in cholesterol = 0.77, 95% confidence interval: 0.64, 0.94), with evidence for a dose-effect relation. The association was restricted to women and remained unchanged after adjustment for multiple potential confounders. These findings may indicate a role of lipids in the pathogenesis of Parkinson's disease. Alternatively, they could reflect the strong correlation—especially in women—between levels of serum cholesterol and the antioxidant coenzyme Q10. If confirmed, this would provide further support for an important role of oxidative stress in the pathogenesis of Parkinson's disease.
Url:
DOI: 10.1093/aje/kwj283
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Serum Cholesterol Levels and the Risk of Parkinson's Disease</title><author><name sortKey="De Lau, Lonneke M L" sort="De Lau, Lonneke M L" uniqKey="De Lau L" first="Lonneke M. L." last="De Lau">Lonneke M. L. De Lau</name></author><author><name sortKey="Koudstaal, Peter J" sort="Koudstaal, Peter J" uniqKey="Koudstaal P" first="Peter J." last="Koudstaal">Peter J. Koudstaal</name></author><author><name sortKey="Hofman, Albert" sort="Hofman, Albert" uniqKey="Hofman A" first="Albert" last="Hofman">Albert Hofman</name></author><author><name sortKey="Breteler, Monique M B" sort="Breteler, Monique M B" uniqKey="Breteler M" first="Monique M. B." last="Breteler">Monique M. B. Breteler</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:3C807B0D4A892AA2D4194ADB8C16E28104D7117F</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1093/aje/kwj283</idno><idno type="url">https://api.istex.fr/document/3C807B0D4A892AA2D4194ADB8C16E28104D7117F/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000A39</idno><idno type="wicri:Area/Main/Curation">000907</idno><idno type="wicri:Area/Main/Exploration">001204</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Serum Cholesterol Levels and the Risk of Parkinson's Disease</title><author><name sortKey="De Lau, Lonneke M L" sort="De Lau, Lonneke M L" uniqKey="De Lau L" first="Lonneke M. L." last="De Lau">Lonneke M. L. De Lau</name><affiliation><wicri:noCountry code="syntax">???</wicri:noCountry></affiliation><affiliation><wicri:noCountry code="syntax">???</wicri:noCountry></affiliation></author><author><name sortKey="Koudstaal, Peter J" sort="Koudstaal, Peter J" uniqKey="Koudstaal P" first="Peter J." last="Koudstaal">Peter J. Koudstaal</name><affiliation><wicri:noCountry code="syntax">???</wicri:noCountry></affiliation></author><author><name sortKey="Hofman, Albert" sort="Hofman, Albert" uniqKey="Hofman A" first="Albert" last="Hofman">Albert Hofman</name><affiliation><wicri:noCountry code="syntax">???</wicri:noCountry></affiliation></author><author><name sortKey="Breteler, Monique M B" sort="Breteler, Monique M B" uniqKey="Breteler M" first="Monique M. B." last="Breteler">Monique M. B. Breteler</name><affiliation><wicri:noCountry code="syntax">???</wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j">American Journal of Epidemiology</title><title level="j" type="abbrev">Am. J. Epidemiol.</title><idno type="ISSN">0002-9262</idno><idno type="eISSN">1476-6256</idno><imprint><publisher>Oxford University Press</publisher><date type="published" when="2006-11-15">2006-11-15</date><biblScope unit="volume">164</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="998">998</biblScope><biblScope unit="page" to="1002">1002</biblScope></imprint><idno type="ISSN">0002-9262</idno></series><idno type="istex">3C807B0D4A892AA2D4194ADB8C16E28104D7117F</idno><idno type="DOI">10.1093/aje/kwj283</idno><idno type="local">kwj283</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0002-9262</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson disease</term><term>cholesterol</term><term>cohort studies</term><term>lipid metabolism</term><term>neurodegenerative diseases</term><term>prospective studies</term><term>risk factors</term><term>serum</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Several recent findings suggest a role of lipid and cholesterol metabolism in the pathogenesis of Parkinson's disease. Therefore, the authors examined the association between serum levels of cholesterol and the risk of Parkinson's disease in the prospective, population-based Rotterdam Study among 6,465 subjects aged 55 or more years with repeated in-person examination and on average 9.4 years of follow-up (1990–2004). Higher serum levels of total cholesterol were associated with a significantly decreased risk of Parkinson's disease (age- and sex-adjusted hazard ratio per mmol/liter increase in cholesterol = 0.77, 95% confidence interval: 0.64, 0.94), with evidence for a dose-effect relation. The association was restricted to women and remained unchanged after adjustment for multiple potential confounders. These findings may indicate a role of lipids in the pathogenesis of Parkinson's disease. Alternatively, they could reflect the strong correlation—especially in women—between levels of serum cholesterol and the antioxidant coenzyme Q10. If confirmed, this would provide further support for an important role of oxidative stress in the pathogenesis of Parkinson's disease.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Breteler, Monique M B" sort="Breteler, Monique M B" uniqKey="Breteler M" first="Monique M. B." last="Breteler">Monique M. B. Breteler</name><name sortKey="De Lau, Lonneke M L" sort="De Lau, Lonneke M L" uniqKey="De Lau L" first="Lonneke M. L." last="De Lau">Lonneke M. L. De Lau</name><name sortKey="Hofman, Albert" sort="Hofman, Albert" uniqKey="Hofman A" first="Albert" last="Hofman">Albert Hofman</name><name sortKey="Koudstaal, Peter J" sort="Koudstaal, Peter J" uniqKey="Koudstaal P" first="Peter J." last="Koudstaal">Peter J. Koudstaal</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001204 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001204 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:3C807B0D4A892AA2D4194ADB8C16E28104D7117F
|texte= Serum Cholesterol Levels and the Risk of Parkinson's Disease
}}
| This area was generated with Dilib version V0.6.23. |  |